Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Sorafenib
Related studies linked through entity extraction aliases.
Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1
- Status
- WITHDRAWN
- Phase
- PHASE2
Second Line Sorafenib After Pazopanib in Patients With RCC
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib for Hepatopulmonary Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors
- Status
- UNKNOWN
- Phase
- NA
Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Sorafenib Chemoembolization Evaluation Controlled Trial
- Status
- COMPLETED
- Phase
- PHASE3
Randomized Trial Sorafenib-Pravastatin Versus Sorafenib Alone for the Palliative Treatment of Child-Pugh A Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
A Safety, Tolerability, and Pharmacokinetics Study of Onartuzumab as Single Agent or in Combination With Sorafenib in Participants With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein
- Status
- TERMINATED
- Phase
- PHASE3
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)
- Status
- TERMINATED
- Phase
- PHASE4
Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract
- Status
- COMPLETED
- Phase
- PHASE1